Teprotumumab Biosimilar (IGF1R / CD221 Reference Antibody)
Teprotumumab is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab attenuates TSH-dependent IL-6 and IL-8 expression and Akt phosphorylation. Teprotumumab can be used for thyroid-associated ophthalmopathy research.
Product Specifications
Target
Teprotumumab Biosimilar (Anti-IGF1R / CD221 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-61499R-PerCP-01 20 µL
TLR9 Recombinant Antibody, PerCP Conjugated
Sign In for Pricing
View Details bsm-61499R-PerCP-02 100 µL
TLR9 Recombinant Antibody, PerCP Conjugated
Sign In for Pricing
View Details 
225919 220 Roll (220 Marker (s) x 1 Roll)
PMNL-RETOUR-GR4-RLL090 Pipe Markers for Water
Sign In for Pricing
View Details MBS6296021-01 0.2 mL
EphA7, NT (EPHA7, EHK3, HEK11, Ephrin type-A receptor 7, EPH homology kinase 3, EPH-like kinase 11) (Biotin)
Sign In for Pricing
View Details MBS6296021-02 5x 0.2 mL
EphA7, NT (EPHA7, EHK3, HEK11, Ephrin type-A receptor 7, EPH homology kinase 3, EPH-like kinase 11) (Biotin)
Sign In for Pricing
View Details